🎥 New on #OncologyBytes from #IUCS2024
Dr. Anupama Vijay shares a real-world UK audit of 1L mRCC treatment.
📊 Only 64% of patients received 2L therapy after progression.
📺 Watch: youtu.be/Qix6-H83_nw
🌐 Learn more at: oncoassist.com

#mRCC #RenalCancer #CheckpointInhibitors #Oncoassist #UKOncology